T2 Biosystems (NASDAQ:TTOO) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of TTOO stock opened at $0.21 on Thursday. T2 Biosystems has a 52-week low of $0.20 and a 52-week high of $6.95. The business has a 50-day simple moving average of $0.35 and a 200-day simple moving average of $1.64.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.